Chronic opioid use is associated with increased DNA methylation correlating with increased clinical pain (original) (raw)
Pharmacogenomics in pain treatment
Jérôme Busserolles
Drug metabolism and personalized therapy, 2016
View PDFchevron_right
Effect of short-term prescription opioids on DNA methylation of the OPRM1 promoter
Jose Vladimir Sandoval Sierra
2020
View PDFchevron_right
Opioids for chronic pain: molecular and genomic basis of actions and adverse effects
Jason Boland, Sam Ahmedzai
Current Opinion in Supportive and Palliative Care, 2007
View PDFchevron_right
Genomewide Study of Epigenetic Biomarkers of Opioid Dependence in European- American Women
Janitza Montalvo-Ortiz
Scientific Reports
View PDFchevron_right
Using the Phenogen website for ‘in silico’ analysis of morphine-induced analgesia: identifying candidate genes
Sanjiv Bhave
Addiction Biology, 2011
View PDFchevron_right
Epigenetic understanding of pain mechanisms and modern treatment perspectives
Jadwiga Jośko-Ochojska
BÓL, 2019
View PDFchevron_right
Pharmacogenetics of chronic pain management
Prateek Lala
Clinical Biochemistry, 2014
View PDFchevron_right
Pharmacogenetics and chronic pain management.
Prateek Lala
Clinical Biochemistry, 2014
View PDFchevron_right
Genome-wide association study identifies a potent locus associated with human opioid sensitivity
Toshiya Inada
Molecular Psychiatry, 2012
View PDFchevron_right
Emergent biomarker derived from next-generation sequencing to identify pain patients requiring uncommonly high opioid doses
Prof. Dr. rer. nat. habil. Alfred Ultsch
View PDFchevron_right
Authors' Response to Peer Reviews of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study” (Preprint)
Mary Jane Marines
2022
View PDFchevron_right
Functional genomics of pain in analgesic drug development and therapy
Prof. Dr. rer. nat. habil. Alfred Ultsch
View PDFchevron_right
Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities
Michael Burczynski
Nature Reviews Neurology
View PDFchevron_right
Authors' Response to Peer Reviews of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”
Mary Jane Marines
JMIRx med, 2022
View PDFchevron_right
Genetic-epigenetic interaction modulates -opioid receptor regulation
Alexandra Doehring, Bruno Oertel
Human Molecular Genetics, 2012
View PDFchevron_right
Pharmacogenetic guidance: individualized medicine promotes enhanced pain outcomes
Jeffrey Fudin
Journal of pain research, 2018
View PDFchevron_right
Continuing war on pain: a personalized approach to the therapy with nonsteroidal anti-inflammatory drugs and opioids
Dragan Primorac
Personalized Medicine, 2018
View PDFchevron_right
Effects of pharmacogenomic (PGx) testing on clinical pain management prescriptions, a retrospective study
Mary Jane Marines
2021
View PDFchevron_right
Genetic Testing for Opioid Pain Management: A Primer
Andrea Trescot
Pain and Therapy, 2017
View PDFchevron_right
Decoding the role of epigenetics and genomics in pain management
Angela Starkweather, Vincent Pair
Pain management nursing : official journal of the American Society of Pain Management Nurses, 2013
View PDFchevron_right
Convergence of case-specific epigenetic alterations identify a confluence of genetic vulnerabilities tied to opioid dependence
Cynthia Bartels
2021
View PDFchevron_right
Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study
Mary Jane Marines
JMIRx med, 2022
View PDFchevron_right
Will Widespread Synthetic Opioid Consumption Induce Epigenetic Consequences in Future Generations?
Marc Augsburger
Frontiers in pharmacology, 2018
View PDFchevron_right
Pharmacogenomics of Analgesic Agents
Amy Drendel
Clinical Pediatric Emergency Medicine, 2007
View PDFchevron_right
The pharmacogenomics of pain management: prospects for personalized medicine
Stephan Schug
Journal of pain research, 2016
View PDFchevron_right
A Genetic Analysis of Opioid-induced Hyperalgesia in Mice
Jianmei Wang
Anesthesiology, 2006
View PDFchevron_right
Genetic behavioral screen identifies an orphan anti-opioid system
Chenghui Song
Science
View PDFchevron_right
PROGRESS IN GENETIC PAIN STUDIES REGARDING ANALGESICS THERAPY-A Systemic Review PART I-GENETIC MODULATION OF PAIN from genotype-phenotype
Veronica Bild
2018
View PDFchevron_right
Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation/Genotypes Changes in Patients with Chronic Pain
Monica Escorial
Journal of Clinical Medicine, 2023
View PDFchevron_right
The role for epigenetic modifications in pain and analgesia response
Sherrie Lessans
Nursing research and practice, 2013
View PDFchevron_right
Are Epigenetic Factors Implicated in Chronic Widespread Pain?
Gregory Livshits
PLOS ONE, 2016
View PDFchevron_right
Influence from genetic variability on opioid use for cancer pain: A European genetic association study of 2294 cancer pain patients
R. Sabatowski
PAIN, 2011
View PDFchevron_right
Genetic Predictors of the Clinical Response to Opioid Analgesics
Carsten Skarke
Clinical Pharmacokinetics, 2004
View PDFchevron_right
Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers
Rainer Freynhagen
Pharmacogenetics and Genomics, 2009
View PDFchevron_right
Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters
hack sun choi
Molecular and cellular biology, 2007
View PDFchevron_right